184 related articles for article (PubMed ID: 25085585)
1. Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.
Liu T; Zuo L; Li L; Yin L; Liang K; Yu H; Ren H; Zhou W; Jing H; Liu Y; Kong C
Tumour Biol; 2014 Nov; 35(11):10911-8. PubMed ID: 25085585
[TBL] [Abstract][Full Text] [Related]
2. FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls.
Zhong-Xing Z; Yuan-Yuan M; Hai Zhen M; Jian-Gang Z; Li-Feng Z
PLoS One; 2013; 8(8):e73700. PubMed ID: 24014103
[TBL] [Abstract][Full Text] [Related]
3. Association between the FAS rs2234767G/A polymorphism and cancer risk: a systematic review and meta-analysis.
Wang X; Xing GH; Fan CC
DNA Cell Biol; 2014 May; 33(5):320-7. PubMed ID: 24568648
[TBL] [Abstract][Full Text] [Related]
4. Fas -670A/G (rs1800682) polymorphism and digestive cancer risk in Asians: a meta-analysis.
Yuan HP; Liu QD; Li GQ; Cong YQ
Genet Test Mol Biomarkers; 2014 Jul; 18(7):482-8. PubMed ID: 24800976
[TBL] [Abstract][Full Text] [Related]
5. Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leukemia, Colorectal, and Esophageal Cancer.
Xu B; Zhu Y; Tang Y; Zhang Z; Wen Q
Med Sci Monit; 2018 Oct; 24():7057-7071. PubMed ID: 30286050
[TBL] [Abstract][Full Text] [Related]
6. Association between the HSPA1B ±1267A/G polymorphism and cancer risk: a meta-analysis of 14 case-control studies.
Kuang D; Chen W; Song YZ; Yu YY; Zhang DY; Wu L; Tang J
Asian Pac J Cancer Prev; 2014; 15(16):6855-61. PubMed ID: 25169537
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between Fas rs180082 polymorphism and risk of cervical cancer: an update by meta-analysis.
Chen X; Mo W; Peng Q; Su X
BMC Med Genet; 2013 Jul; 14():71. PubMed ID: 23865866
[TBL] [Abstract][Full Text] [Related]
8. Fas -670 A/G polymorphism predicts prognosis of hepatocellular carcinoma after curative resection in Chinese Han population.
Guo XY; Xia YL; Li ZY; Li R; Fan Y; Yao WM; Liu F
Hepatobiliary Pancreat Dis Int; 2022 Feb; 21(1):33-40. PubMed ID: 34366198
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.
Wang Z; Gu J; Nie W; Xu J; Huang G; Guan X
Tumour Biol; 2014 Apr; 35(4):3035-9. PubMed ID: 24248546
[TBL] [Abstract][Full Text] [Related]
10. PLCE1 rs2274223 polymorphism and susceptibility to esophageal cancer: a meta-analysis.
Guo LY; Yang N; Hu D; Zhao X; Feng B; Zhang Y; Zhai M
Asian Pac J Cancer Prev; 2014; 15(21):9107-12. PubMed ID: 25422186
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-α 238 G/A polymorphism and risk of hepatocellular carcinoma: evidence from a meta-analysis.
Cheng K; Zhao YJ; Liu L; Wan JJ
Asian Pac J Cancer Prev; 2013; 14(5):3275-9. PubMed ID: 23803115
[TBL] [Abstract][Full Text] [Related]
12. Associations between Fas/FasL polymorphisms and susceptibility to cervical cancer: a meta-analysis.
Wang GQ; Bao L; Zhao XX; Zhang J; Nan KJ
Tumour Biol; 2014 May; 35(5):4107-12. PubMed ID: 24375196
[TBL] [Abstract][Full Text] [Related]
13. Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia.
Chen Y; Wang H; Yan Y; Ren M; Yan C; Wang B
Medicine (Baltimore); 2019 Dec; 98(49):e18240. PubMed ID: 31804351
[TBL] [Abstract][Full Text] [Related]
14. Association between FAS 1377G>A polymorphism and breast cancer susceptibility: a meta-analysis.
Li K; Li W; Zou H; Zhao L
Tumour Biol; 2014 Jan; 35(1):351-6. PubMed ID: 23979975
[TBL] [Abstract][Full Text] [Related]
15. Association between FAS-1377 G/A polymorphism and susceptibility to gastric cancer: evidence from a meta-analysis.
Wu Z; Wang H; Chu X; Chen J; Fang S
Tumour Biol; 2013 Aug; 34(4):2147-52. PubMed ID: 23636796
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
17. Association between FAS gene -670 A/G and -1377 G/A polymorphisms and the risk of autoimmune diseases: a meta-analysis.
Yan H; Hong Y; Cai Y
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31840751
[TBL] [Abstract][Full Text] [Related]
18. Association of Fas-670 gene polymorphism with risk of cervical cancer in North Indian population.
Kordi Tamandani DM; Sobti RC; Shekari M
Clin Exp Obstet Gynecol; 2008; 35(3):183-6. PubMed ID: 18754288
[TBL] [Abstract][Full Text] [Related]
19. Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis.
Huang D; Xiao J; Deng X; Ma K; Liang H; Shi D; Wu F; Shao Z
BMC Musculoskelet Disord; 2018 May; 19(1):137. PubMed ID: 29734947
[TBL] [Abstract][Full Text] [Related]
20. Association between FAS A670G polymorphism and susceptibility to cervical cancer: evidence from a meta-analysis.
Shen J; Sun NX
Tumour Biol; 2013 Dec; 34(6):3443-8. PubMed ID: 23900676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]